The limitations of our study are 1) the most participants were positioned in provincial hospitals only, 2) the private hospitals or clinics were not included, so our results may not be representative of those who attend asthma clinics in other settings of Thailand. asthma severity score, severe asthma exacerbations, acute asthma
Conditions
Interventions
patients who received more than 2 doses of nebulized short acting beta 2 agonists, patients received more than 2 doses of nebulized short acting beta 2 agonists with at least 1 dose of ipratropium bro
Diagnostic,Diagnostic
outcome 1,outcome 2
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
2 Years to 15 Years
Inclusion criteria
Inclusion criteria: 1.asthmatic children aged 2 to 15 years who developed asthma exacerbations at the ED of Buddhasothorn Hospital between January 2018 and December 2020
Exclusion criteria
Exclusion criteria: 1.patients had underlying chronic diseases bronchopulmonary dysplasia (interstitial lung disease, congenital heart disease, or congenital anomalies), 2. Patients who had received systemic corticosteroids within 28 days before each episode of acute asthma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| severe asthma exacerbations at 12 months after end of the study asthma severity scores | — |
Secondary
| Measure | Time frame |
|---|---|
| cut-points to predict severe exacerbations of asthma at 12 months after end of the study asthma severity scores | — |
Countries
Thailand
Contacts
Public ContactSuttipong Ittiporn
Buddhasothorn Hospital
Outcome results
None listed